Professional Documents
Culture Documents
doi: 10.1093/eep/dvw020
Research article
RESEARCH ARTICLE
Abstract
Maternal smoking during pregnancy (MSDP) has detrimental effects on fetal development and on the health of the offspring
into adulthood. Energy homeostasis through ATP production via the mitochondria (mt) plays a key role during pregnancy.
This study aimed to determine if MSDP resulted in differences in DNA methylation to the placental mitochondrial chromo-
some at the transcription and replication control region, the D-Loop, and if these differences were also present in an alter-
nate neonatal tissue (foreskin) in an independent birth cohort. We investigated mtDNA methylation by bisulfite-
pyrosequencing in two sections of the D-Loop control region and in long interspersed nuclear element-1 (LINE-1) genomic
sequences in placenta from 96 mother–newborn pairs that were enrolled in a Rhode Island birth cohort along with foreskin
samples from 62 infants from a Kentucky birth cohort. In both placenta and foreskin, mtDNA methylation in the light chain
D-Loop region 1 was positively associated with MSDP in placenta (difference þ2.73%) (P ¼ 0.001) and foreskin (differ-
ence þ 1.22%) (P ¼ 0.08). Additionally, in foreskin, a second segment of the D-Loop-heavy chain region 1 showed a small but
significant change in methylation with MSDP (þ 0.4%, P ¼ 0.04). No methylation changes were noted in either tissue at the
LINE-1 repetitive element. We identified a similar pattern of epigenetic effect to mitochondria arising in cells from different
primordial lineages and in different populations, associated with MSDP. These robust and consistent results build evidence
that MSDP may impact mt D-Loop methylation, as one mechanism through which this exposure affects newborn health.
1
2 | Environmental Epigenetics, 2016, Vol. 2, No. 3
Introduction A D-Loop
(576-16024)
Understanding the role of environmental and lifestyle exposures
Heavy Chain 0
on inter-generational health has been the subject of many recent TSS
studies [1–6]. Cigarette smoking, specifically maternal smoking 12S 15953
after delivery but prior to discharge, mothers participated in an and clinical data were abstracted from a thorough review of the
interviewer-administered structured questionnaire to obtain in- maternal and neonatal electronic medical records (EMR).
formation on demographics, prenatal health behaviors, medical Smoking status before pregnancy was ascertained at the first
history, information on various lifestyle exposures (including prenatal visit, as documented in the intake questionnaire in the
smoking and recreational drug use), occupational histories, and outpatient maternal EMR system. Smoking status during preg-
personal care product usage. Smoking was retrospectively as- nancy was verified based on the documentation of the same in
sessed as over the lifetime, 3 months prior to pregnancy, and the maternal EMR during the course of ongoing prenatal care
during each trimester of pregnancy, asking participants about and the status at the time of delivery was similarly confirmed
the types of cigarettes used (filtered or nonfiltered, menthol, or using EMR at the time of presentation for delivery. Patients who
nonmenthol) and the average number of packs of cigarette were noted to have been smoking at the beginning of pregnancy
smoked per day during these periods. Between September 1, (1st prenatal visit) but had quit smoking during the ongoing
2009, and July 31, 2013, 1150 eligible infants were identified and course of prenatal care or at the time of delivery—were consid-
721 enrolled (63%). Study protocols were approved by the ered as “smoking quitters,” while the remainder were deemed
Maternal
Age, mean (range) 29.18 (18–40) 27.91 (20–39) 27.14 (20–38) 0.35
BMI
Normal 17 (45.95%) 9 (39.13%) 18 (50%) 0.45
Overweight 7 (18.92%) 8 (34.78%) 10 (27.78%)
Obese 12 (32.43%) 6 (26.09%) 6 (16.67%)
Maternal education
< 11th grade 2 (5.41%) 0 11 (30.56%) 0.002
High school graduate 9 (24.32%) 10 (43.48%) 9 (25%)
Junior college 10 (27.03%) 7 (30.43%) 12 (33.33%)
College graduate 10 (27.03%) 4 (17.39%) 4 (11.11%)
the standard deviation of the mean of the triplicate group. DNA were demographic differences within our groupings, we used a
methylation across all CpG sites within each assay was aver- Fisher’s exact test and one-way ANOVA to compare count and
aged to obtain average percent methylation for analysis. continuous data, respectively. All data were analyzed using the R
statistical environment v3.2.4. Data underlying these analyses can
be provided for purposes of verification by contacting the authors.
mtDNA Content Analysis
Relative mtDNA content was measured from placental tissue by
a quantitative real-time PCR assay by determining the ratio of
Results
mitochondrial copy number to a single copy gene [23, 24]. The
reference single copy gene used in this study was human globin RICHS study subject characteristics are listed in Table 1. Overall,
(beta). Primers used for mtDNA content were identical to those mothers in the study were on average 28.1 years old, with no dif-
previously described [23]. ferences in maternal age depending on smoking status. Maternal
body mass index also did not differ based on smoking status. Non-
smoking mothers tended to have the highest level of maternal ed-
Statistical Analysis ucation with 55.6% FT, 43.5% 1T, and 29.7% of NS mothers having
For each region of interest, Pearson correlation indicated that val- attained a high-school education or less. Infant sex did not differ
ues across loci within the region were strongly correlated (r > 0.75). across the maternal smoking groups, but as expected, FT preg-
Due to this, we took the average methylation value for each indi- nancy smokers had a greater proportion of infants consider small
vidual across the loci measured here. A Shapiro–Wilk test was per- for gestational age (50%) compared to first term only (17%) or non-
formed for both the RICHS and Kentucky cohorts in order to smokers (NS) (16%). Infants of non-smoking mothers showed the
determine whether methylation values were normally distributed highest overall birth weight average at 3666.0 g, with the 1T and FT
for LDLR1, HDLR1, and LINE1. In both the RICHS and Kentucky co- pregnancy smokers showing a 7.4% (3378.48 g) and 17.85%
horts LINE1 methylation was normally distributed while LDLR1 (3011.5 g) reduction in birth weight, respectively. The average ges-
and HDLR1 methylation was not normally distributed. tational age for each group was similar. Finally, pack years ((ciga-
Associations between maternal smoking status during preg- rettes/day/20)/years of smoking) was used to evaluate differences
nancy and DNA methylation for RICHS were determined by 1-way in lifetime primary smoke exposures between the 1T smokers and
analysis of variance (ANOVA) or by Kruskal–Wallis one-way FT pregnancy smokers. No differences were noted (P ¼ 0.56).
ANOVA for normally and non-normally distributed data, respec- Pyrosequencing assays were designed to measure DNA
tively. A Dunn’s multiple comparisons test was performed post methylation of the mitochondrial chromosome on the light
hoc in order to determine the relationship between smoking status chain in D-Loop region (LDLR) as shown in Figure 1. As a mark
and methylation. Within the Kentucky cohort, the extent of meth- of genomic global methylation, LINE-1 repetitive region was
ylation was associated with smoking status by Student’s t-test or also quantified. Median methylation was evaluated in both co-
by Mann–Whitney U test for normally and non-normally distrib- horts in LDLR1 and HDLR1 assays as the data were not normally
uted data, respectively. Descriptive statistics were calculated for distributed; however, LINE-1 assay data were normally distrib-
each smoking status grouping, and to determine whether there uted; therefore, mean methylation was reported.
Armstrong et al. | 5
Figure 2: Mitochondrial and global methylation associated with maternal smoking during pregnancy in placenta. Median methylation % was measured for each pyro-
sequencing assay from placenta of mothers comparing NS (n ¼ 37), 1T smokers (n ¼ 23) and FT pregnancy smokers (n ¼ 36). Mitochondrial LDLR1 showed significantly
increased methylation in full pregnancy smokers (P ¼ 0.001, Kruskal-Wallis, NS to FT P ¼ 0.001, Dunn’s post hoc) (A). HDLR1 (B) showed no differences in methylation
Figure 3: Mitochondrial and global methylation associated with maternal smoking during pregnancy in foreskin. Median methylation % was measured for each pyro-
sequencing assay from foreskin of infants of the Kentucky birth cohort. Mitochondrial LDLR1 showed a trend of increased methylation in FT pregnancy smokers (n ¼
21) vs. NS (n ¼ 41) (P ¼ 0.08, Mann–Whitney) (A). Mitochondrial HDLR1 showed significantly increased methylation in FT pregnancy smokers (n ¼ 20) vs. NS (n ¼ 38) (P ¼
methylation changes in two different tissues (i.e. placenta and to hypothesize that epigenetic alterations at specific targeted lo-
foreskin), from two different birth cohorts, associated with ma- cations on the mitochondrial chromosome may impact tran-
ternal smoking during pregnancy. scription and/or replication of the mitochondrial DNA,
Our initial strategy was to develop a mitochondrial specific subsequent mitochondrial gene expression and perhaps even
methylation assay that was contained within the D-Loop con- regulation of oxidative phosphorylation. Such changes could af-
trol region of the mitochondrial chromosome, as this region fect the proper functioning of placental trophoblasts, and thus
contains the transcription start sites for both the light and could have various effects on placental activity and fetal
heavy chains and the heavy chain DNA replication start site, development.
and we observed a positive association between MSDP and mi- Previous studies have found both positive [37] or negative
tochondrial D-Loop methylation. Several previous studies have [13] association between mtDNA count number (mtDNAcn) and
demonstrated methylation at the mitochondrial D-Loop from a environmental exposures. And both higher [38] and lower [39]
variety of cell types and tissues [13, 29] including the work of placental mtDNAcn have been reported associated with ciga-
Bianchessi et al. [30] in endothelial cells at region LSR4 that over- rette smoking during pregnancy. We did not see differences in
laps with our assay, but none have demonstrated the methyla- placental mtDNAcn associated with maternal smoking in our
tion differences we see comparing smoking to non-smoking study (online Supplementary material, Fig. S2). It is possible
mothers. Janssen et al. [13] investigated methylation changes in that our small sample size does not afford us enough power to
placenta in a Belgian birth cohort associated with airborne par- discern a clear trend.
ticulates and found that placental mtDNA methylation is posi- To determine if the D-Loop methylation differences associ-
tively associated with particulate matter exposure during ated with MSDP in placenta were specific to this tissue, we exam-
gestation. Other work that addresses mitochondrial D-Loop ined newborn foreskin from an independent birth cohort.
methylation includes Feng et al. [31] who investigated the corre- Foreskin, a tissue that is rich in various cell types including fibro-
lation between ND2 expression and D-Loop methylation in colo- blasts, epidermal keratinocytes, T cells, and Langerhans cells, has
rectal cancer and Pirola et al. [32] examined D-Loop methylation been used in vitro studies for >50 years [40]. More recently, how-
in the setting of nonalcoholic fatty liver disease; however, these ever, genome-wide DNA methylation profiling has been reported
latter two studies are difficult to directly compare to our results from foreskin [41] and comparative analysis of human mitochon-
as their approach uses methylation specific PCR and either ra- drial methylomes [42]. Nonetheless, our study is the first that we
tios of methylated/unmethylated in study participants or per- are aware of to examine infant mitochondrial methylation in re-
cent of total samples methylated across the study population, lation to smoking during pregnancy. The similarity between D-
and not the extent of methylation across the regions examined. Loop % methylation increase comparing smoking vs. non-
Consistent with a prior study that found that placental geno- smoking in the RICHS birth cohort vs. Kentucky birth cohort is re-
mic DNA methylation changes with smoking at specific CpG di- markable at 2.73% vs. 1.22%, respectively. We do note, however,
nucleotides [27, 33], we found methylation increases at specific that there may be one influential point in the Kentucky placental
D-Loop mtDNA CpGs (LDLR1) in placenta and at two D-Loop seg- LDLR1 assay and we have tested the relationship between LDLR1
ments—LDLR1 and HDLR1—in a second tissue, foreskin. mean methylation and smoking status within the Kentucky co-
However, no significant changes were seen in genomic methyla- hort removing the single data point resulting in a difference
tion of LINE-1 sequence. Several previous studies have reported of þ0.73% and P ¼ 0.14. Considering that cigarette smoke toxicity
global methylation changes in infant DNA associated with ma- depends not only on the intrinsic characteristics of the toxic com-
ternal smoking [2, 25, 33–35]; however, neither placenta nor fore- ponents in the environmental stress but also on the individual
skin were examined in these studies. This global methylation susceptibility of the subjects exposed to the cigarette smoke [36],
discrepancy may have to do with fact that each tissue has a the fact that such similarities could be observed in these distinct
unique epigenetic signature that likely reflects differential func- populations and in two different infant tissue types, is notable.
tions [20]. Additionally, methylation of the D-Loop region itself Additionally, the observation of significant mtDNA methylation
may be a cell/tissue type-specific or even gender-specific phe- in a second segment of the D-Loop (HDLR1) in one tissue but not
nomenon. Further studies are needed to address and clarify this in the other may again reflect the type of epigenetic tissue or cell-
issue. specificity as seen in other studies [20, 43, 44] or even a gender-
Mitochondria certainly contain the machinery required to specific phenomenon. Further studies are needed to address and
epigenetically modify mtDNA [36]. Consequently, it is plausible clarify this issue.
Armstrong et al. | 7
Historically, the observed methylation of the mtDNA has smoking in two independent birth cohorts and alternate tissue
been very low (1–6%) [37, 45]. Our observations are mostly con- types. The exact mechanisms responsible for changes in mito-
sistent with previous results, with the exception of our smokers chondrial methylation and ultimately the effects on fetal devel-
placental group higher at 8.45%. With the placenta being a phys- opment and growth remain to be determined but areas of
ical and functional connection between mother and developing potential interest for investigation may include intrauterine hyp-
infant, fulfilling not only metabolic and endocrine functions but oxia or specific chemical constituents of tobacco smoke. In addi-
also serving a protective role, namely, helping to reduce the tion, it will be important to examine if these differences in
transfer of potentially toxic substances to the developing em- mtDNA methylation can be linked to long-term outcome in these
bryo/fetus [46], it might not be surprising with environmental infants, and so follow-up in longitudinal studies is warranted.
exposures to observe higher levels of mtDNA methylation in the
placenta itself as opposed to lower mtDNA methylation in an al-
ternate infant tissue, as we observe here. Funding
Furthermore, the exact temporal influence of environmental
This work was supported by the U.S. National Institutes of
8. Lowe CR. Effect of mothers’ smoking habits on birth weight of tobacco use modestly alters correlated epigenome-wide pla-
their children. Br Med J 1959;2: 673–676. cental DNA methylation and gene expression. Epigenetics
9. Maccani JZ, Maccani MA. Altered placental DNA methylation 2011;6: 1284–1294.
patterns associated with maternal smoking: current perspec- 28. Lambertini L, Byun HM. Mitochondrial epigenetics and envi-
tives. Adv Genomics Genet 2015;2015: 205–214. ronmental exposure. Curr Environ Health Rep 2016;3: 214–24.
10. Knopik VS, Maccani MA, Francazio S, McGeary JE. The epige- 29. Bellizzi D, D’Aquila P, Scafone T, Giordano M, Riso V, Riccio A,
netics of maternal cigarette smoking during pregnancy and ef- Passarino G.. The control region of mitochondrial DNA shows
fects on child development. Dev Psychopathol 2012;24: 1377–1390. an unusual CpG and non-CpG methylation pattern. DNA Res
11. Paquette AG, Marsit CJ. The developmental basis of epige- 2013;20: 537–547.
netic regulation of HTR2A and psychiatric outcomes. J Cell 30. Bianchessi V, Vinci MC, Nigro P, Rizzi V, Farina F, Capogrossi
Biochem 2014;115: 2065–2072. MC, Pompilio G, Gualdi V, Lauri A. Methylation profiling by bi-
12. Ghosh S, Singh KK, Sengupta S, Scaria V. Mitoepigenetics: sulfite sequencing analysis of the mtDNA Non-Coding Region
The different shades of grey. Mitochondrion 2015;25: 60–66. in replicative and senescent Endothelial Cells. Mitochondrion
13. Janssen BG, Byun HM, Gyselaers W, Lefebvre W, Baccarelli 2016;27: 40–47.
epigenetic regulation in mitochondria. Mitochondrion 2014;18: 48. Ghosh S, Sengupta S, Scaria V. Hydroxymethyl cytosine
58–62. marks in the human mitochondrial genome are dynamic in
43. Wan J, Oliver VF, Wang G, Zhu H, Zack DJ, Merbs SL, Qian J. nature. Mitochondrion 2016;27: 25–31.
Characterization of tissue-specific differential DNA methyla- 49. Sen A, Heredia N, Senut MC, Hess M, Land S, Qu W, Hollacher
tion suggests distinct modes of positive and negative gene K, Dereski MO, Ruden DM. Early life lead exposure causes
expression regulation. BMC Genomics 2015;16: 49. gender-specific changes in the DNA methylation profile of
44. Huang YT, Chu S, Loucks EB, Lin CL, Eaton CB, Buka SL, Kelsey DNA extracted from dried blood spots. Epigenomics 2015;7:
KT. Epigenome-wide profiling of DNA methylation in paired 379–393.
samples of adipose tissue and blood. Epigenetics 2016;11: 50. Hall E, Volkov P, Dayeh T, Esguerra JL, Salö S, Eliasson L, Rönn
227–236. T, Bacos K, Ling C. Sex differences in the genome-wide DNA
45. Maresca A, Zaffagnini M, Caporali L, Carelli V, Zanna C. DNA methylation pattern and impact on gene expression,
methyltransferase 1 mutations and mitochondrial pathology: microRNA levels and insulin secretion in human pancreatic
is mtDNA methylated? Front Genet 2015;6: 90. islets. Genome Biol 2014;15: 522.
46. Gude NM, Roberts CT, Kalionis B, King RG. Growth and function 51. Campesi I, Carru C, Zinellu A, Occhioni S, Sanna M, Palermo